Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Neuvonen

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9X Wen, J S Wang, J T Backman, et al.
British Journal of Anaesthesia|March 1, 1993
Haemodynamic and catecholamine responses to induction of anaesthesia and tracheal intubation: comparison between propofol and thiopentoneL Lindgren, A Yli-Hankala, T Randell, et al.
Brain & Development|January 1, 1988
Can barbiturate anaesthesia cure infantile spasms?R Riikonen, P Santavuori, O Meretoja, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1982
Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolitesP J Pentikäinen, A Penttilä, P J Neuvonen, et al.
Acta Anaesthesiologica Scandinavica|October 1, 1989
Thiopentone pharmacokinetics during cardiopulmonary bypass with a nonpulsatile or pulsatile flowM Hynynen, K T Olkkola, E Näveri, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Triazolam is ineffective in patients taking rifampinK Villikka, K T Kivistö, J T Backman, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1982
Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamatesR G Khalifah, C E Hignite, P J Pentikäinen, et al.
Human & Experimental Toxicology|August 4, 1998
A prospective study of acute poisonings in Finnish hospital patientsO Lapatto-Reiniluoto, K T Kivistö, S Pohjola-Sintonen, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukastT Karonen, A Filppula, J Laitila, et al.
Clinical Pharmacology and Therapeutics|September 8, 2000
Plasma concentrations of active simvastatin acid are increased by gemfibrozilJ T Backman, C Kyrklund, K T Kivistö, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9X Wen, J S Wang, J T Backman, et al.
British Journal of Anaesthesia|March 1, 1993
Haemodynamic and catecholamine responses to induction of anaesthesia and tracheal intubation: comparison between propofol and thiopentoneL Lindgren, A Yli-Hankala, T Randell, et al.
Brain & Development|January 1, 1988
Can barbiturate anaesthesia cure infantile spasms?R Riikonen, P Santavuori, O Meretoja, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1982
Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolitesP J Pentikäinen, A Penttilä, P J Neuvonen, et al.
Acta Anaesthesiologica Scandinavica|October 1, 1989
Thiopentone pharmacokinetics during cardiopulmonary bypass with a nonpulsatile or pulsatile flowM Hynynen, K T Olkkola, E Näveri, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Triazolam is ineffective in patients taking rifampinK Villikka, K T Kivistö, J T Backman, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1982
Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamatesR G Khalifah, C E Hignite, P J Pentikäinen, et al.
Human & Experimental Toxicology|August 4, 1998
A prospective study of acute poisonings in Finnish hospital patientsO Lapatto-Reiniluoto, K T Kivistö, S Pohjola-Sintonen, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukastT Karonen, A Filppula, J Laitila, et al.
Clinical Pharmacology and Therapeutics|September 8, 2000
Plasma concentrations of active simvastatin acid are increased by gemfibrozilJ T Backman, C Kyrklund, K T Kivistö, et al.
Pageof 34